Therapeutic Market Research Reports
Sort By
Title | Published | Price |
---|---|---|
2021 United Therapeutics SWOT Analysis--Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to ... |
Jan 2021 | $ 750 |
Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiase... |
Jan 2021 | $ 125 |
Yumanity Therapeutics Inc (YMTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Yumanity Therapeutics Inc (YMTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un... |
Jan 2021 | $ 125 |
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias... |
Jan 2021 | $ 125 |
Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear ... |
Jan 2021 | $ 125 |
Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Travere Therapeutics Inc (TVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Jan 2021 | $ 125 |
Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Jan 2021 | $ 125 |
Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review
By GlobalData
Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Dec 2020 | $ 125 |
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Dec 2020 | $ 125 |
Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an u... |
Dec 2020 | $ 125 |
Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an... |
Dec 2020 | $ 125 |
Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Stealth BioTherapeutics Corp (MITO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an... |
Dec 2020 | $ 125 |
Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Dec 2020 | $ 125 |
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review
By GlobalData
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un... |
Dec 2020 | $ 125 |
Melinta Therapeutics Inc - Strategic SWOT Analysis Review
By GlobalData
Melinta Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's k... |
Dec 2020 | $ 125 |
Asia Pacific Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2021-2028
By Inkwood Research
KEY FINDINGS
The Asia Pacific Alzheimer's disease therapeutics and diagnostics market is estimated to register a CAGR of 5.67% during the forecast period, 2021-2028. The increasing number of age-induced dementia cases is set to propel market g... |
Dec 2020 | $ 1250 |
Europe Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2021-2028
By Inkwood Research
KEY FINDINGS
The Europe Alzheimer's disease therapeutics and diagnostics market is estimated to record a CAGR of 5.59% during the forecast period, 2021-2028. The surging population is the main driver of market growth in the European region.... |
Dec 2020 | $ 1250 |
North America Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2021-2028
By Inkwood Research
KEY FINDINGS
The North America Alzheimer's disease therapeutics and diagnostics market is set to evolve at a CAGR of 5.24% during the forecast period, 2021-2028. The advanced healthcare system and rising healthcare expenditure are among the im... |
Dec 2020 | $ 1250 |
Japan Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2021-2025
By Inkwood Research
KEY FINDINGS
The Japan Alzheimer's disease therapeutics and diagnostics market is estimated to record a CAGR of 5.82% during the forecast period, 2021-2025. The increasing R&D activities are augmenting the market growth in Japan. 2020 is the b... |
Dec 2020 | $ 700 |
Fortovia Therapeutics Inc - Strategic SWOT Analysis Review
By GlobalData
Fortovia Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's ... |
Nov 2020 | $ 125 |
Osiris Therapeutics Inc - Strategic SWOT Analysis Review
By GlobalData
Osiris Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's ke... |
Nov 2020 | $ 125 |
Allergy Therapeutics plc (AGY) - Financial and Strategic SWOT Analysis Review
By GlobalData
Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbi... |
Nov 2020 | $ 125 |
Marker Therapeutics Inc (MRKR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Marker Therapeutics Inc (Marker Therapeutics) is formerly known as TapImmune Inc is a clinical-stage immuno-oncology company focus on the development of innovative peptide, gene-based immuno therapeutics and vaccines for the trea... |
Nov 2020 | $ 300 |
Vivoryon Therapeutics AG (VVY) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Vivoryon Therapeutics AG (Vivoryon) is a clinical-stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer's disease. The company offers three pipeline drug candidates... |
Nov 2020 | $ 300 |
Cyclo Therapeutics Inc (CTDH) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Cyclo Therapeutics Inc (Cyclo Therapeutics), formerly CTD Holdings Inc, is a biotechnology company that develops and manufactures cyclodextrin-based drugs. It is investigating Trappsol Cyclo, an orphan drug against Niemann-Pick ... |
Nov 2020 | $ 300 |